The Biologics and Vaccines CDMO partner of choice.
The Complete Clinical Journey
We can take you from development through commercialization.
As a partner we will support your programs in Preclinical Phase. Our services include Clone Selection, proof of Concept Studies and more.Read More
As a partner we will support your Early Phase Programs. Our services include Process and Analytical Development, Stability, and more.Read More
As a partner we will support your Late Phase Trials. Our services include FMEA- Risk Assessment, Process Validation, and more.Read More
Setting Ourselves Apart for You
What makes us unique?
A commitment to excellence and success in knowing our customers, their needs and the science required to take their project forward.Learn More
Information & Resources
Ask The Expert: Challenges of Scale Up and Development of Insect Cell Culture and BEVS
A strategy for scale up and implementation of Insect Cell Culture should be assessed at the earliest stages of process development as there are a different set of challenges in the culture of ICC and BEVS versus a CHO culture and a limited number of vendors experienced enough to guide you through the adventure of manufacturing ICCWatch Now
Mass Spectrometric Conjugate Characterization: Process Qualification of Recombinant Protein–Hapten Conjugation
Here we present case studies in development of reliable methods based on mass spectrometry (MS) to characterize a protein–hapten drug substance during late-phase process validation. This protein is modified by succinylation to enable conjugation with an aminated hapten.Read More
Site Specific PEGylation at Histidine Tags
John Liddell, Ian Hodgson and Charles Heise are co-authors of this paper, in conjuntion with PolyTherics Limited, and UCL School of Pharmacy. The article, which describes the covalent conjustation of PEG site-specifically to a polyhistidine tag (His-tag) on a protein, can be viewed online on Bioconjugate Chemistry.Download